Most read article(s)

Research
Visual tests predict dementia risk in Parkinson disease
Louise-Ann Leyland, Fion D. Bremner, Ribeya Mahmood, et al.

September 18, 2019
Review
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
Nicholas E. Johnson, Eugenio Zapata Aldana, Nathalie Angeard, et al.

April 24, 2019
The Nerve! Readers Speak
Reader response: Consensus-based care recommendations for adults with myotonic dystrophy type 1
Tuy Nga Brignol, Patrice E. Fort

October 14, 2019
Research
Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice
Carrie M. Hersh, Haleigh Harris, Devon Conway, et al.

February 12, 2020
The Nerve! Readers Speak
Reader response: Clinical utility of therapeutic drug monitoring of antiepileptic drugs
Nitin K. Sethi

February 10, 2020
Case
Serum sickness following rituximab therapy in multiple sclerosis
Trygve Holmøy, Anna Fogdell-Hahn, Anders Svenningsson

July 12, 2019
From the Editor's Desk
Issue highlights
February 10, 2020
Research
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, et al.

January 02, 2020
Research
Symptom burden among individuals with Parkinson diseaseA national survey
Christopher G. Tarolli, Grace A. Zimmerman, Peggy Auinger, et al.

November 18, 2019
From the Editor's Desk
Issue highlights
December 09, 2019

Pages